mdgl stocktwits：Madrigal Pharmaceuticals Inc (MDGL) News
Madrigal Pharmaceuticals Inc (MDGL) News
FindMadrigalPharmaceuticalsInc(MDGL)news,corporateevents,pressreleases,latestcompanyupdatesandheadlines.。其他文章還包含有：「Earnings」、「MadrigalPharmaceuticals(MDGL)StockForecast&Price...」、「MadrigalPharmaceuticalsInc(MDGL)Fundamental&...」、「MadrigalPharmaceuticalsInc(MDGL)sentimentscore...」、「MadrigalPharmaceuticals,Inc.(MDGL)StockPrice」、「MDGLConversationsFromStockTwits」、「MDGL...
查看更多 離開網站
Earnings
https://stocktwits.com
Checkout Madrigal Pharmaceuticals Inc (MDGL) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods.
Madrigal Pharmaceuticals (MDGL) Stock Forecast & Price ...
https://www.tipranks.com
Based on 8 Wall Street analysts offering 12 month price targets for Madrigal Pharmaceuticals in the last 3 months. The average price target is $330.43 with a ...
Madrigal Pharmaceuticals Inc (MDGL) Fundamental & ...
https://stocktwits.com
Get all financial information for Madrigal Pharmaceuticals Inc (MDGL) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, ...
Madrigal Pharmaceuticals Inc (MDGL) sentiment score ...
https://stocktwits.com
Discover Madrigal Pharmaceuticals Inc (MDGL) market and community sentiment, movement in message volume, participation score and buzz level in the ...
Madrigal Pharmaceuticals, Inc. (MDGL) Stock Price
https://finance.yahoo.com
MDGL - Madrigal Pharmaceuticals, Inc. NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 236.54. -11.99 (-4.82%). At close: February 23 04:00PM EST.
MDGL Conversations From StockTwits
https://stocknews.com
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe ...
MDGL Madrigal Pharmaceuticals Inc
https://stocktwits.com
MDGL Madrigal Pharmaceuticals Inc. 5,628. $236.54. $11.99. (4.82%). Today. Market Cap, $4.67B. 52-Wk High, $322.67. 52-Wk Low, $119.76. ST Data. Watchers.
Synta Pharmaceuticals Corp. (SNTA) News
https://stocktwits.com
--- - Zacks Investment Research lowered shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) from a hold rating to a sell rating in a report published on Wednesday ...